<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">JAMA Neurol</journal-id><journal-id journal-id-type="iso-abbrev">JAMA Neurol</journal-id><journal-id journal-id-type="pmc-domain-id">3211</journal-id><journal-id journal-id-type="pmc-domain">jamasd</journal-id><journal-title-group><journal-title>JAMA Neurology</journal-title></journal-title-group><issn pub-type="ppub">2168-6149</issn><issn pub-type="epub">2168-6157</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>JAMA Network</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10043806</article-id><article-id pub-id-type="pmcid-ver">PMC10043806.1</article-id><article-id pub-id-type="pmcaid">10043806</article-id><article-id pub-id-type="pmcaiid">10043806</article-id><article-id pub-id-type="pmid">36972059</article-id><article-id pub-id-type="doi">10.1001/jamaneurol.2023.0339</article-id><article-id pub-id-type="publisher-id">noi230010</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="category" specific-use="electronic"><subject>Research</subject></subj-group><subj-group subj-group-type="domain" specific-use="print"><subject>Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Investigation</subject></subj-group><subj-group subj-group-type="featured" specific-use="electronic"><subject>Featured</subject></subj-group><subj-group subj-group-type="online-first"><subject>Online First</subject></subj-group><subj-group subj-group-type="allowCommenting"><subject>Comments</subject></subj-group></article-categories><title-group><article-title>Association of Dementia Risk With Focal Epilepsy and Modifiable Cardiovascular Risk Factors</article-title><alt-title alt-title-type="headline">Association of Dementia Risk With Focal Epilepsy and Modifiable Cardiovascular Risk Factors</alt-title><alt-title alt-title-type="running-head">Association of Dementia Risk With Focal Epilepsy and Modifiable Cardiovascular Risk Factors</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Tai</surname><given-names initials="XY">Xin You</given-names></name><degrees>MD</degrees><xref rid="noi230010aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="noi230010aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Torzillo</surname><given-names initials="E">Emma</given-names></name><degrees>MD</degrees><xref rid="noi230010aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lyall</surname><given-names initials="DM">Donald M.</given-names></name><degrees>PhD</degrees><xref rid="noi230010aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Manohar</surname><given-names initials="S">Sanjay</given-names></name><degrees>DPhil</degrees><xref rid="noi230010aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="noi230010aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="noi230010aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Husain</surname><given-names initials="M">Masud</given-names></name><degrees>DPhil</degrees><xref rid="noi230010aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="noi230010aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="noi230010aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sen</surname><given-names initials="A">Arjune</given-names></name><degrees>DPhil</degrees><xref rid="noi230010aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="noi230010aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="noi230010aff6" ref-type="aff">
<sup>6</sup>
</xref></contrib></contrib-group><aff id="noi230010aff1"><label>1</label>Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom</aff><aff id="noi230010aff2"><label>2</label>Division of Clinical Neurology, John Radcliffe Hospital, Oxford University Hospitals Trust, Oxford, United Kingdom</aff><aff id="noi230010aff3"><label>3</label>Epilepsy Department, National Hospital for Neurology and Neurosurgery, University College London, London, United Kingdom</aff><aff id="noi230010aff4"><label>4</label>Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom</aff><aff id="noi230010aff5"><label>5</label>Department of Experimental Psychology, University of Oxford, Oxford, United Kingdom</aff><aff id="noi230010aff6"><label>6</label>Oxford Epilepsy Research Group, NIHR Biomedical Research Centre, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, United Kingdom</aff><author-notes><title>Article Information</title><p><bold>Accepted for Publication:</bold> January 26, 2023.</p><p content-type="published-online"><bold>Published Online:</bold> March 27, 2023. doi:<uri content-type="doi">10.1001/jamaneurol.2023.0339</uri></p><p content-type="open-access-note"><bold>Open Access:</bold> This is an open access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://jamanetwork.com/pages/cc-by-license-permissions" ext-link-type="uri">CC-BY License</ext-link>. &#169; 2023 Tai XY et al. <italic toggle="yes">JAMA Neurology</italic>.</p><corresp id="noi230010cor1"><bold>Corresponding Author:</bold> Xin You Tai, MD, John Radcliffe Hospital, Level 6, West Wing, University of Oxford, Oxford OX3 9DU, United Kingdom (<email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="xin.tai@ndcn.ox.ac.uk">xin.tai@ndcn.ox.ac.uk</email>).</corresp><p content-type="author-contributions"><bold>Author Contributions:</bold> Dr Tai had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Drs Husain and Sen contributed equally as co&#8211;senior authors.</p><p><italic toggle="yes">Concept and design:</italic> Tai, Torzillo, Sen, Manohar.</p><p><italic toggle="yes">Acquisition, analysis, or interpretation of data:</italic> Tai, Lyall, Sen, Manohar, Husain.</p><p><italic toggle="yes">Drafting of the manuscript:</italic> Tai, Manohar.</p><p><italic toggle="yes">Critical revision of the manuscript for important intellectual content:</italic> All authors.</p><p><italic toggle="yes">Statistical analysis:</italic> Tai, Torzillo, Manohar.</p><p><italic toggle="yes">Obtained funding:</italic> Manohar, Husain.</p><p><italic toggle="yes">Administrative, technical, or material support:</italic> Manohar, Husain.</p><p><italic toggle="yes">Supervision:</italic> Lyall, Sen, Manohar, Husain.</p><p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> Dr Torzillo reported that her position as clinical research fellow at University of Oxford from July 2019 to July 2020 was funded through a UCB research grant outside the submitted work. Dr Sen reported grants from the National Institutes of Health and Oxford Biomedical Research Centre during the conduct of the study. Dr Husain reported grants from Wellcome Trust during the conduct of the study. No other disclosures were reported.</p><p content-type="funding-statement"><bold>Funding/Support:</bold> This work was funded by the Wellcome Trust (a Wellcome Trust PhD clinical fellowship to Dr Tai and Wellcome Trust principal research fellowship to Dr Husain) and Medical Research Council (a Clinician Scientist Fellowship to Dr Manohar) and by the Oxford NIHR Biomedical Research Centre.</p><p><bold>Role of the Funder/Sponsor:</bold> The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p><p content-type="data-sharing-statement"><bold>Data Sharing Statement:</bold> See <xref rid="note-NOI230010-1-s" ref-type="supplementary-material">Supplement 2</xref>.</p></author-notes><pub-date pub-type="epub" iso-8601-date="2023-03-27T10:00"><day>27</day><month>3</month><year>2023</year></pub-date><pub-date pub-type="ppub"><month>5</month><year>2023</year></pub-date><volume>80</volume><issue>5</issue><issue-id pub-id-type="pmc-issue-id">432150</issue-id><fpage>445</fpage><lpage>454</lpage><history><date date-type="received"><day>18</day><month>10</month><year>2022</year></date><date date-type="accepted"><day>26</day><month>1</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>27</day><month>03</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>29</day><month>03</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-11-07 18:25:18.337"><day>07</day><month>11</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>Copyright 2023 Tai XY et al. <italic toggle="yes">JAMA Neurology</italic>.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the CC-BY License.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jamaneurol-e230339.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf-version" xlink:href="jamaneurol-e230339.pdf">jamaneurol-e230339.pdf</self-uri><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="silverchair" xlink:href="https://jamanetwork.com/journals/archneur/fullarticle/10.1001/jamaneurol.2023.0339"/><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="commentary" xml:lang="en" xlink:title="article-commentary" journal-id="Epilepsy Curr" journal-id-type="nlm-ta" ext-link-type="pmc" xlink:href="PMC10601029"><article-title>Epilepsy, Cardiovascular Risks, and Dementia: A M&#233;nage &#224; Trois</article-title><volume>23</volume><issue>5</issue><date><day>9</day><month>8</month><year>2023</year></date><fpage>283</fpage><lpage>285</lpage><source>Epilepsy Currents</source><pub-id pub-id-type="doi">10.1177/15357597231189588</pub-id><pub-id pub-id-type="pmcid">PMC10601029</pub-id><pub-id pub-id-type="pmid">37901785</pub-id></related-article><abstract abstract-type="teaser" specific-use="electronic"><p>This cross-sectional study examines data from the UK Biobank to explore the association between focal epilepsy compared with stroke or migraine and the risk of developing dementia and how that risk is affected by modifiable cardiovascular risk factors.</p></abstract><abstract abstract-type="key-points"><title>Key Points</title><sec id="ab-noi230010-1"><title>Question</title><p>To what extent does having focal epilepsy compared with stroke or migraine increase the risk of developing dementia, and how is it affected by modifiable cardiovascular risk factors?</p></sec><sec id="ab-noi230010-2"><title>Findings</title><p>This cross-sectional study of 495&#8201;149 participants aged 38 to 72 years without dementia at baseline demonstrated that participants with epilepsy and high cardiovascular risk were more than 13 times more likely to develop dementia compared with control participants with low cardiovascular risk while participants with stroke and high cardiovascular risk were almost 6 times more likely to develop dementia. Having epilepsy was associated with higher incident dementia risk than a history of stroke.</p></sec><sec id="ab-noi230010-3"><title>Meaning</title><p>This study found that epilepsy was associated with a significant risk of developing dementia, which was magnified substantially by cardiovascular risk.</p></sec></abstract><abstract><sec id="ab-noi230010-4"><title>Importance</title><p>Epilepsy has been associated with cognitive impairment and potentially dementia in older individuals. However, the extent to which epilepsy may increase dementia risk, how this compares with other neurological conditions, and how modifiable cardiovascular risk factors may affect this risk remain unclear.</p></sec><sec id="ab-noi230010-5"><title>Objective</title><p>To compare the differential risks of subsequent dementia for focal epilepsy compared with stroke and migraine as well as healthy controls, stratified by cardiovascular risk.</p></sec><sec id="ab-noi230010-6"><title>Design, Setting, and Participants</title><p>This cross-sectional study is based on data from the UK Biobank, a population-based cohort of more than 500&#8201;000 participants aged 38 to 72 years who underwent physiological measurements and cognitive testing and provided biological samples at 1 of 22 centers across the United Kingdom. Participants were eligible for this study if they were without dementia at baseline and had clinical data pertaining to a history of focal epilepsy, stroke, or migraine. The baseline assessment was performed from 2006 to 2010, and participants were followed up until 2021.</p></sec><sec id="ab-noi230010-7"><title>Exposures</title><p>Mutually exclusive groups of participants with epilepsy, stroke, and migraine at baseline assessment and controls (who had none of these conditions). Individuals were divided into low, moderate, or high cardiovascular risk groups based on factors that included waist to hip ratio, history of hypertension, hypercholesterolemia, diabetes, and smoking pack-years.</p></sec><sec id="ab-noi230010-8"><title>Main Outcomes and Measures</title><p>Incident all-cause dementia; measures of executive function; and brain total hippocampal, gray matter, and white matter hyperintensity volumes.</p></sec><sec id="ab-noi230010-9"><title>Results</title><p>Of 495&#8201;149 participants (225&#8201;481 [45.5%] men; mean [SD] age, 57.5 [8.1] years), 3864 had a diagnosis of focal epilepsy only, 6397 had a history of stroke only, and 14&#8201;518 had migraine only. Executive function was comparable between participants with epilepsy and stroke and worse than the control and migraine group. Focal epilepsy was associated with a higher risk of developing dementia (hazard ratio [HR], 4.02; 95% CI, 3.45 to 4.68; <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001), compared with stroke (HR, 2.56; 95% CI, 2.28 to 2.87; <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001), or migraine (HR, 1.02; 95% CI, 0.85 to 1.21; <italic toggle="yes">P</italic>&#8201;=&#8201;.94). Participants with focal epilepsy and high cardiovascular risk were more than 13 times more likely to develop dementia (HR, 13.66; 95% CI, 10.61 to 17.60; <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001) compared with controls with low cardiovascular risk. The imaging subsample included 42&#8201;353 participants. Focal epilepsy was associated with lower hippocampal volume (mean difference, &#8722;0.17; 95% CI, &#8722;0.02 to &#8722;0.32; <italic toggle="yes">t</italic>&#8201;=&#8201;&#8722;2.18; <italic toggle="yes">P</italic>&#8201;=&#8201;.03) and lower total gray matter volume (mean difference, &#8722;0.33; 95% CI, &#8722;0.18 to &#8722;0.48; <italic toggle="yes">t</italic>&#8201;=&#8201;&#8722;4.29; <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001) compared with controls. There was no significant difference in white matter hyperintensity volume (mean difference, 0.10; 95% CI, &#8722;0.07 to 0.26; <italic toggle="yes">t</italic>&#8201;=&#8201;1.14; <italic toggle="yes">P</italic>&#8201;=&#8201;.26).</p></sec><sec id="ab-noi230010-10"><title>Conclusions and Relevance</title><p>In this study, focal epilepsy was associated with a significant risk of developing dementia, to a greater extent than stroke, which was magnified substantially in individuals with high cardiovascular risk. Further findings suggest that targeting modifiable cardiovascular risk factors may be an effective intervention to reduce dementia risk in individuals with epilepsy.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="H1-1-NOI230010"><title>Introduction</title><p>Epilepsy is a common neurological condition characterized by unprovoked seizures. The incidence of epilepsy is highest in older life and progressively increases after 55 years of age.<sup><xref rid="noi230010r1" ref-type="bibr">1</xref>,<xref rid="noi230010r2" ref-type="bibr">2</xref>,<xref rid="noi230010r3" ref-type="bibr">3</xref></sup> As individuals with epilepsy age, studies suggest an increased risk of cognitive impairment and potentially dementia.<sup><xref rid="noi230010r4" ref-type="bibr">4</xref>,<xref rid="noi230010r5" ref-type="bibr">5</xref></sup> However, the extent to which epilepsy affects dementia risk and potential underlying mechanisms remains unclear. In addition, there are no specific clinical guidelines around mitigating the risk of dementia in epilepsy.</p><p>While recent evidence has highlighted a shared pathology link of tau accumulation in epilepsy and dementia,<sup><xref rid="noi230010r6" ref-type="bibr">6</xref>,<xref rid="noi230010r7" ref-type="bibr">7</xref>,<xref rid="noi230010r8" ref-type="bibr">8</xref></sup> another intriguing line of inquiry is the role of modifiable cardiovascular risk factors that contribute to dementia risk in the general aging population.<sup><xref rid="noi230010r9" ref-type="bibr">9</xref>,<xref rid="noi230010r10" ref-type="bibr">10</xref></sup> Established stroke is a risk factor for developing epilepsy in older adults<sup><xref rid="noi230010r11" ref-type="bibr">11</xref></sup>; however, the effect of upstream cardiovascular risk factors is less clear with conflicting findings.<sup><xref rid="noi230010r12" ref-type="bibr">12</xref>,<xref rid="noi230010r13" ref-type="bibr">13</xref></sup> Similarly, while poststroke epilepsy is considered predictive of cognitive outcomes,<sup><xref rid="noi230010r14" ref-type="bibr">14</xref></sup> how dementia risk in epilepsy may change according to an individual&#8217;s burden of modifiable cardiovascular risk factors in the absence of stroke remains unknown.</p><p>A recent systematic review<sup><xref rid="noi230010r5" ref-type="bibr">5</xref></sup> identified disease duration, seizure frequency, and antiseizure medication use as potential predictors of cognitive impairment in epilepsy, although studies were limited by small samples of patients and controls and the lack of consideration for lifestyle and cardiovascular risk factors.<sup><xref rid="noi230010r15" ref-type="bibr">15</xref>,<xref rid="noi230010r16" ref-type="bibr">16</xref>,<xref rid="noi230010r17" ref-type="bibr">17</xref></sup> Correspondingly, a meta-analysis examining dementia risk in epilepsy identified similar limitations and was unable to calculate period prevalence owing to insufficient pooled sample size.<sup><xref rid="noi230010r3" ref-type="bibr">3</xref></sup> To guide clinical management, it is important to understand the epilepsy-related dementia risk compared with other neurological conditions to provide comparator context for clinical decisions.</p><p>In this study, we analyzed the risk associated with developing dementia across a range of neurological conditions in the UK Biobank prospective cohort. Specifically, our aim was to determine the extent to which focal-onset epilepsy is associated with risk of developing dementia compared with individuals with stroke or migraine, 2 other nondegenerative neurological conditions, as well as healthy controls. We hypothesized that epilepsy would be associated with higher dementia incidence than migraine and controls but less than stroke, which is strongly linked to vascular cognitive impairment and dementia. Further, we determined the extent to which having low cardiovascular risk is associated with reduced risk of dementia in epilepsy as this may help develop dementia risk reduction strategies for people with epilepsy.</p></sec><sec id="H1-2-NOI230010"><title>Methods</title><p>This cross-sectional study is based on data from the UK Biobank, a population-based cohort of more than 500&#8201;000 participants aged 38 to 72 years who underwent physiological measurements and cognitive testing and provided biological samples at 1 of 22 centers across the United Kingdom between 2006 and 2010.<sup><xref rid="noi230010r18" ref-type="bibr">18</xref></sup> A subset of participants reattended for brain imaging between 2014 and 2020.<sup><xref rid="noi230010r19" ref-type="bibr">19</xref></sup> All participants provided written informed consent. UK Biobank received approval from the North West Multicenter Research Ethics Committee. This study followed the Strengthening the Reporting of Observational Studies in Epidemiology (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.equator-network.org/reporting-guidelines/strobe/" ext-link-type="uri">STROBE</ext-link>) reporting guideline.</p><p>The primary study objective was to investigate the risk of incident dementia associated with having focal epilepsy compared with stroke or migraine and healthy controls at baseline study assessment. Participants with prevalent dementia at baseline assessment (&lt;1%) were excluded as were those with other neurological conditions, including a history of central nervous system infection, encephalitis, meningitis, amyotrophic lateral sclerosis, multiple sclerosis, Parkinson disease, or previous subdural or subarachnoid hemorrhage. Baseline diagnoses were identified using self-report and hospital inpatient records (UK Biobank codes are found in eTable 1 in <xref rid="note-NOI230010-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p><sec id="H2-1-NOI230010"><title>Dementia and Focal Epilepsy Diagnoses</title><p>All-cause dementia cases were identified during longitudinal follow-up from hospital inpatient records using codes from the <italic toggle="yes">International Classification of Diseases, Ninth Revision</italic> (<italic toggle="yes">ICD-9</italic>), and <italic toggle="yes">International Statistical Classification of Diseases and Related Health Problems, Tenth Revision</italic> (<italic toggle="yes">ICD-10</italic>), for Alzheimer disease and other dementia classifications or from death register linkage data as an underlying or contributory cause.</p><p>The epilepsy subgroup was restricted to focal-onset, nongenetic epilepsy at baseline based on <italic toggle="yes">ICD</italic> codes. We excluded individuals coded for a genetically associated epilepsy, including &#8220;generalized idiopathic epilepsy and epileptic syndromes&#8221; (G40.3), such as syndromes of juvenile myoclonic epilepsy and childhood absence epilepsies, and &#8220;other generalized epilepsy and epileptic syndromes&#8221; (G40.4), which includes epileptic encephalopathies such as Lennox-Gaustaut and West syndrome, because these can be associated with clear cognitive deficits related to an underlying genetic mechanism or developmental delay.<sup><xref rid="noi230010r20" ref-type="bibr">20</xref></sup> To investigate the potential confounding effects of antiseizure medication, we compared the association between cognitive scores and number of antiseizure medications (list in eTable 2 in <xref rid="note-NOI230010-1-s" ref-type="supplementary-material">Supplement 1</xref>) for individuals with a diagnosis of focal epilepsy and those without a diagnosis but taking the medication for another reason. Information on seizure onset zone in the brain was not available; however, the majority of focal-onset, acquired epilepsy may be of temporal lobe origin.<sup><xref rid="noi230010r21" ref-type="bibr">21</xref></sup></p></sec><sec id="H2-2-NOI230010"><title>Cardiovascular Risk Score</title><p>Cardiovascular risk was assessed based on a previously published score<sup><xref rid="noi230010r22" ref-type="bibr">22</xref></sup> with a point given for a diagnosis or being treated for hypertension, high cholesterol, or diabetes (1 point for each condition), waist to hip ratio (1 point if greater than the sex-specific threshold set by World Health Organization guidelines),<sup><xref rid="noi230010r23" ref-type="bibr">23</xref></sup> smoking pack-years (1 point if more than 20 pack-years), and <italic toggle="yes">APOE</italic> e4 allele status (2 points for 2 e4 alleles, 1 for a single e4 allele, and 0 for any other allele combination or when allele status was unclear). Participants were placed in low- (a score of 0), moderate- (1 and 2), or high-risk (&#8805;3) groups based on quintile boundaries 1, 2 to 4, and 5, respectively.</p></sec><sec id="H2-3-NOI230010"><title>Cognitive Testing</title><p>UK Biobank cognitive testing was computer-based and performed at the initial baseline visit, repeated at the imaging visit, and taken via online questionnaire. Not all cognitive tasks were performed at each instance while some were repeated. We analyzed data from 5 tasks of working memory or speed of processing and used the first available time point data. This included a pairs-matching and snap reaction time, trail-making, tower-rearranging, and symbol-digit substitution tasks and has been described in detail elsewhere.<sup><xref rid="noi230010r24" ref-type="bibr">24</xref></sup> Reliability and retest effects over time for these cognitive tasks have been previously assessed.<sup><xref rid="noi230010r25" ref-type="bibr">25</xref></sup></p></sec><sec id="H2-4-NOI230010"><title>Main Covariates</title><p>All full models were adjusted for age (continuous), sex (female vs male), education (categorized as higher [college or university degree or other professional qualification], upper secondary [second or final stage of secondary education], lower secondary [first stage of secondary education], vocational [work-related qualifications], or other), socioeconomic status (categories derived from Townsend deprivation index<sup><xref rid="noi230010r26" ref-type="bibr">26</xref></sup> quintiles 1, 2 to 4, and 5), and cardiovascular risk group.</p></sec><sec id="H2-5-NOI230010"><title>Brain Imaging Variables</title><p>Magnetic resonance imaging (MRI) data were acquired on a Skyra 3-T scanner (Siemens), including high-resolution, T1-weighted, 3-dimensional magnetization-prepared gradient echo structural images and T2-weighted fluid-attenuated inversion recovery images. Full imaging protocols and processing pipeline have been previously described.<sup><xref rid="noi230010r27" ref-type="bibr">27</xref></sup> We used imaging summary statistics of total hippocampal, gray matter, and white matter hyperintensity volumes. These regions were chosen because previous epilepsy studies have found hippocampal atrophy<sup><xref rid="noi230010r28" ref-type="bibr">28</xref>,<xref rid="noi230010r29" ref-type="bibr">29</xref>,<xref rid="noi230010r30" ref-type="bibr">30</xref></sup> and hippocampal tau deposition.<sup><xref rid="noi230010r6" ref-type="bibr">6</xref></sup> Total gray matter volume is a useful measure of widespread, global change while white matter hyperintensity is a useful marker of vascular burden. Median absolute deviation was used to exclude outliers, and volumes were adjusted for potentially confounding baseline measures of age, age squared, head size, and imaging site.<sup><xref rid="noi230010r27" ref-type="bibr">27</xref></sup></p></sec><sec id="H2-6-NOI230010"><title>Statistical Analysis</title><p>Confirmatory factor analysis (CFA) was performed on cognitive variables to produce a continuous, summary latent measure of working memory and reaction time, which we termed <italic toggle="yes">executive function</italic> for simplicity (this method has been previously described).<sup><xref rid="noi230010r22" ref-type="bibr">22</xref>,<xref rid="noi230010r24" ref-type="bibr">24</xref></sup> In brief, cognitive variables were preprocessed to correct for heavily skewed distribution prior to CFA. Standard fit indices were measured with higher comparative fit index and Tucker-Lewis index considered better (&gt;0.9 are commonly used as acceptable fit cutoffs) while lower root mean square error of approximation and standardized root mean square error residual are considered better (&lt;0.06 and &lt;0.08, respectively, are commonly used cutoffs for acceptable fit). Estimating a latent variable has the methodological advantage of controlling measurement error that can artificially reduce the relationship between measured variables in standard univariate analyses.<sup><xref rid="noi230010r31" ref-type="bibr">31</xref></sup> Missing cognitive data were estimated using full information maximum likelihood, which gives unbiased parameter estimates and standard errors.</p><p>We examined mutually exclusive groups of focal epilepsy, stroke, and migraine. Combinations of conditions, such as having epilepsy and stroke, were not reported because of the small sample sizes. The association between executive function across age was examined for each group. We then controlled for age in 2 different ways for robustness: using a model-free, sliding window approach with fixed age-quantile widths moved along the age distribution (described previously<sup><xref rid="noi230010r24" ref-type="bibr">24</xref>,<xref rid="noi230010r32" ref-type="bibr">32</xref>,<xref rid="noi230010r33" ref-type="bibr">33</xref></sup>) or by including age as a covariate in a general linear model along with other baseline characteristics. We compared the difference in executive function between condition groups using analysis of variance with post hoc Tukey analysis to account for pairwise or multiple comparisons. <italic toggle="yes">P</italic> values were 2-sided with statistical significance set at <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.05 for all analyses. Brain measures were analyzed in the epilepsy subgroup using the same methods.</p><p>Hazard ratios (HRs) were calculated using Cox proportional hazards regression models with time to incident all-cause dementia as the dependent variable. We calculated HRs for mutually exclusive groups of focal epilepsy, stroke, and migraine compared with none of these conditions as the baseline. For our main model, we tested the dementia risk associated with having focal epilepsy, stroke, or neither condition, stratified by cardiovascular risk groups (9 categories with low cardiovascular risk and neither epilepsy or stroke as the baseline). The migraine subgroup had similar HRs to those for the control group from initial testing and was not included in this model. For the main exposures and covariates, there were less than 3% missing or not known data, and complete case analysis was applied. Participants were considered at risk for dementia from baseline until the date of first diagnosis, death, loss to follow-up, or last surveyed hospital admission date (March 31, 2021, for England and Scotland and February 28, 2018, for Wales), whichever came first. These censoring dates were recommended by UK Biobank as the data were estimated to be more than 90% complete in England, Scotland, and Wales.</p><p>Secondary data analyses examined dementia risk with different follow-up durations of 10 years and 5 to 14 years to consider earlier risk of developing dementia and potential reverse causality, respectively. Further sensitivity analysis considered dementia risk associated with stroke and epilepsy stratified by a cardiovascular risk score that did not include <italic toggle="yes">APOE</italic> e4 genetic information to consider only modifiable lifestyle risk. The association between dementia risk and epilepsy controlling for number of antiseizure medications was investigated within the epilepsy subgroup only. Analyses were done in MATLAB R2018a or in R version 4.0.3 using the lavaan<sup><xref rid="noi230010r34" ref-type="bibr">34</xref></sup> or survival package.</p></sec></sec><sec id="H1-3-NOI230010"><title>Results</title><p>The UK Biobank cohort comprised 502&#8201;536 participants at baseline. After excluding those who did not meet the inclusion criteria (n&#8201;=&#8201;7216) and those with prevalent dementia at baseline (n&#8201;=&#8201;120), our study included 495&#8201;149 individuals (eFigure 1 in <xref rid="note-NOI230010-1-s" ref-type="supplementary-material">Supplement 1</xref>). Participants had a mean (SD) age of 57.5 (8.1) years, and 250&#8201;752 (54.5%) were female (<xref rid="noi230010t1" ref-type="table">Table</xref>). Over 5&#8201;803&#8201;006 total follow-up years (median, 12.0 years; IQR, 11.2-12.7), 6115 cases of all-cause incident dementia were observed.</p><table-wrap position="float" id="noi230010t1" orientation="portrait"><label>Table. </label><caption><title>Baseline Characteristics of Study Participants</title></caption><table frame="hsides" rules="groups"><col width="16.14%" span="1"/><col width="11.39%" span="1"/><col width="9.39%" span="1"/><col width="10.74%" span="1"/><col width="10.75%" span="1"/><col width="11.42%" span="1"/><col width="9.39%" span="1"/><col width="11.39%" span="1"/><col width="9.39%" span="1"/><thead><tr><th rowspan="3" valign="top" align="left" scope="col" colspan="1">Characteristic</th><th colspan="8" valign="top" align="left" scope="colgroup" rowspan="1">No. (%)<xref rid="noi230010t1n1" ref-type="table-fn"><sup>a</sup></xref></th></tr><tr><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Control group</th><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Epilepsy</th><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Stroke</th><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Migraine</th></tr><tr><th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">No incident dementia</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Incident dementia</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">No incident dementia</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Incident dementia</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">No incident dementia</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Incident dementia</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">No incident dementia</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Incident dementia</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">No. of participants</td><td valign="top" align="left" rowspan="1" colspan="1">464&#8201;138</td><td valign="top" align="left" rowspan="1" colspan="1">5471</td><td valign="top" align="left" rowspan="1" colspan="1">4121</td><td valign="top" align="left" rowspan="1" colspan="1">198</td><td valign="top" align="left" rowspan="1" colspan="1">6679</td><td valign="top" align="left" rowspan="1" colspan="1">337</td><td valign="top" align="left" rowspan="1" colspan="1">15&#8201;835</td><td valign="top" align="left" rowspan="1" colspan="1">174</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Age, mean (SD), y</td><td valign="top" align="left" rowspan="1" colspan="1">57.4 (8.1)</td><td valign="top" align="left" rowspan="1" colspan="1">65.3 (4.8)</td><td valign="top" align="left" rowspan="1" colspan="1">57.1 (8.1)</td><td valign="top" align="left" rowspan="1" colspan="1">63.5 (6.1)</td><td valign="top" align="left" rowspan="1" colspan="1">61.5 (6.9)</td><td valign="top" align="left" rowspan="1" colspan="1">65.4 (4.7)</td><td valign="top" align="left" rowspan="1" colspan="1">56.1 (7.8)</td><td valign="top" align="left" rowspan="1" colspan="1">63.7 (6.2)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Sex</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Female</td><td valign="top" align="left" rowspan="1" colspan="1">250&#8201;752 (54.0)</td><td valign="top" align="left" rowspan="1" colspan="1">2619 (47.9)</td><td valign="top" align="left" rowspan="1" colspan="1">2071 (50.3)</td><td valign="top" align="left" rowspan="1" colspan="1">77 (38.9)</td><td valign="top" align="left" rowspan="1" colspan="1">2766 (41.4)</td><td valign="top" align="left" rowspan="1" colspan="1">119 (35.3)</td><td valign="top" align="left" rowspan="1" colspan="1">12&#8201;363 (78.1)</td><td valign="top" align="left" rowspan="1" colspan="1">117 (67.2)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Male</td><td valign="top" align="left" rowspan="1" colspan="1">213&#8201;386 (46.0)</td><td valign="top" align="left" rowspan="1" colspan="1">2852 (52.1)</td><td valign="top" align="left" rowspan="1" colspan="1">2050 (49.7)</td><td valign="top" align="left" rowspan="1" colspan="1">121 (61.1)</td><td valign="top" align="left" rowspan="1" colspan="1">3913 (58.6)</td><td valign="top" align="left" rowspan="1" colspan="1">218 (64.7)</td><td valign="top" align="left" rowspan="1" colspan="1">3472 (21.9)</td><td valign="top" align="left" rowspan="1" colspan="1">57 (32.8)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Education<xref rid="noi230010t1n2" ref-type="table-fn"><sup>b</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Higher</td><td valign="top" align="left" rowspan="1" colspan="1">217&#8201;148 (46.8)</td><td valign="top" align="left" rowspan="1" colspan="1">1813 (33.1)</td><td valign="top" align="left" rowspan="1" colspan="1">1623 (39.4)</td><td valign="top" align="left" rowspan="1" colspan="1">55 (27.8)</td><td valign="top" align="left" rowspan="1" colspan="1">2257 (33.8)</td><td valign="top" align="left" rowspan="1" colspan="1">86 (25.5)</td><td valign="top" align="left" rowspan="1" colspan="1">7810 (49.3)</td><td valign="top" align="left" rowspan="1" colspan="1">53 (30.4)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Upper secondary</td><td valign="top" align="left" rowspan="1" colspan="1">58&#8201;464 (12.6)</td><td valign="top" align="left" rowspan="1" colspan="1">550 (10.1)</td><td valign="top" align="left" rowspan="1" colspan="1">547 (13.3)</td><td valign="top" align="left" rowspan="1" colspan="1">23 (11.6)</td><td valign="top" align="left" rowspan="1" colspan="1">807 (12.1)</td><td valign="top" align="left" rowspan="1" colspan="1">33 (9.8)</td><td valign="top" align="left" rowspan="1" colspan="1">1939 (12.2)</td><td valign="top" align="left" rowspan="1" colspan="1">17 (9.8)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Lower secondary</td><td valign="top" align="left" rowspan="1" colspan="1">25&#8201;227 (5.4)</td><td valign="top" align="left" rowspan="1" colspan="1">253 (4.6)</td><td valign="top" align="left" rowspan="1" colspan="1">202 (4.9)</td><td valign="top" align="left" rowspan="1" colspan="1">10 (5.1)</td><td valign="top" align="left" rowspan="1" colspan="1">302 (4.5)</td><td valign="top" align="left" rowspan="1" colspan="1">19 (5.6)</td><td valign="top" align="left" rowspan="1" colspan="1">919 (5.8)</td><td valign="top" align="left" rowspan="1" colspan="1">11 (6.3)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Vocational</td><td valign="top" align="left" rowspan="1" colspan="1">77&#8201;047 (16.6)</td><td valign="top" align="left" rowspan="1" colspan="1">746 (13.6)</td><td valign="top" align="left" rowspan="1" colspan="1">708 (17.1)</td><td valign="top" align="left" rowspan="1" colspan="1">23 (11.6)</td><td valign="top" align="left" rowspan="1" colspan="1">1045 (15.6)</td><td valign="top" align="left" rowspan="1" colspan="1">42 (12.5)</td><td valign="top" align="left" rowspan="1" colspan="1">2793 (17.6)</td><td valign="top" align="left" rowspan="1" colspan="1">22 (12.6)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Other</td><td valign="top" align="left" rowspan="1" colspan="1">86&#8201;252 (18.6)</td><td valign="top" align="left" rowspan="1" colspan="1">2109 (38.5)</td><td valign="top" align="left" rowspan="1" colspan="1">1047 (25.4)</td><td valign="top" align="left" rowspan="1" colspan="1">85 (42.9)</td><td valign="top" align="left" rowspan="1" colspan="1">2268 (34.0)</td><td valign="top" align="left" rowspan="1" colspan="1">157 (46.6)</td><td valign="top" align="left" rowspan="1" colspan="1">2374 (15.0)</td><td valign="top" align="left" rowspan="1" colspan="1">71 (40.8)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Socioeconomic status quintile<xref rid="noi230010t1n3" ref-type="table-fn"><sup>c</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 1 (Least deprived)</td><td valign="top" align="left" rowspan="1" colspan="1">93&#8201;326 (20.1)</td><td valign="top" align="left" rowspan="1" colspan="1">990 (18.1)</td><td valign="top" align="left" rowspan="1" colspan="1">641 (15.5)</td><td valign="top" align="left" rowspan="1" colspan="1">28 (14.1)</td><td valign="top" align="left" rowspan="1" colspan="1">959 (14.4)</td><td valign="top" align="left" rowspan="1" colspan="1">39 (11.6)</td><td valign="top" align="left" rowspan="1" colspan="1">3161 (20.0)</td><td valign="top" align="left" rowspan="1" colspan="1">31 (17.8)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 2-4</td><td valign="top" align="left" rowspan="1" colspan="1">278&#8201;742 (60.1)</td><td valign="top" align="left" rowspan="1" colspan="1">3151 (57.6)</td><td valign="top" align="left" rowspan="1" colspan="1">2317 (56.2)</td><td valign="top" align="left" rowspan="1" colspan="1">96 (48.5)</td><td valign="top" align="left" rowspan="1" colspan="1">3629 (54.3)</td><td valign="top" align="left" rowspan="1" colspan="1">176 (52.2)</td><td valign="top" align="left" rowspan="1" colspan="1">9588 (60.5)</td><td valign="top" align="left" rowspan="1" colspan="1">91 (52.3)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 5 (Most deprived)</td><td valign="top" align="left" rowspan="1" colspan="1">91&#8201;495 (19.7)</td><td valign="top" align="left" rowspan="1" colspan="1">1323 (24.2)</td><td valign="top" align="left" rowspan="1" colspan="1">1166 (28.2)</td><td valign="top" align="left" rowspan="1" colspan="1">74 (37.4)</td><td valign="top" align="left" rowspan="1" colspan="1">2084 (31.2)</td><td valign="top" align="left" rowspan="1" colspan="1">122 (36.2)</td><td valign="top" align="left" rowspan="1" colspan="1">3061 (19.3)</td><td valign="top" align="left" rowspan="1" colspan="1">52 (29.9)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> NA</td><td valign="top" align="left" rowspan="1" colspan="1">575 (0.1)</td><td valign="top" align="left" rowspan="1" colspan="1">7 (0.1)</td><td valign="top" align="left" rowspan="1" colspan="1">2 (0.05)</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">7 (0.1)</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">25 (0.2)</td><td valign="top" align="left" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Cardiovascular risk group (score)<xref rid="noi230010t1n4" ref-type="table-fn"><sup>d</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Low (0)</td><td valign="top" align="left" rowspan="1" colspan="1">127&#8201;055 (27.3)</td><td valign="top" align="left" rowspan="1" colspan="1">495 (9.0)</td><td valign="top" align="left" rowspan="1" colspan="1">997 (24.2)</td><td valign="top" align="left" rowspan="1" colspan="1">21 (10.6)</td><td valign="top" align="left" rowspan="1" colspan="1">531 (8.0)</td><td valign="top" align="left" rowspan="1" colspan="1">13 (3.9)</td><td valign="top" align="left" rowspan="1" colspan="1">5490 (34.7)</td><td valign="top" align="left" rowspan="1" colspan="1">31 (17.8)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Moderate (1-2)</td><td valign="top" align="left" rowspan="1" colspan="1">258&#8201;527 (55.7)</td><td valign="top" align="left" rowspan="1" colspan="1">2695 (49.3)</td><td valign="top" align="left" rowspan="1" colspan="1">2309 (56.0)</td><td valign="top" align="left" rowspan="1" colspan="1">91 (46.0)</td><td valign="top" align="left" rowspan="1" colspan="1">2700 (40.4)</td><td valign="top" align="left" rowspan="1" colspan="1">97 (28.8)</td><td valign="top" align="left" rowspan="1" colspan="1">8585 (54.2)</td><td valign="top" align="left" rowspan="1" colspan="1">87 (50.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> High (&#8805;3)</td><td valign="top" align="left" rowspan="1" colspan="1">78&#8201;556 (16.9)</td><td valign="top" align="left" rowspan="1" colspan="1">2281 (41.7)</td><td valign="top" align="left" rowspan="1" colspan="1">815 (19.8)</td><td valign="top" align="left" rowspan="1" colspan="1">86 (43.4)</td><td valign="top" align="left" rowspan="1" colspan="1">3448 (51.6)</td><td valign="top" align="left" rowspan="1" colspan="1">227 (67.4)</td><td valign="top" align="left" rowspan="1" colspan="1">1760 (11.1)</td><td valign="top" align="left" rowspan="1" colspan="1">56 (32.2)</td></tr></tbody></table><table-wrap-foot><p>Abbreviation: NA, not available.</p><fn id="noi230010t1n1"><label>
<sup>a</sup>
</label><p>Percentages may not sum to 100 because of rounding.</p></fn><fn id="noi230010t1n2"><label>
<sup>b</sup>
</label><p>Higher education defined as college/university degree or other professional qualification; upper secondary, second/final stage of secondary education; lower secondary, first stage of secondary education; vocational, work-related practical qualifications.</p></fn><fn id="noi230010t1n3"><label>
<sup>c</sup>
</label><p>Socioeconomic status assessed on the Townsend deprivation index, which combines information on social class, employment, car availability, and housing.</p></fn><fn id="noi230010t1n4"><label>
<sup>d</sup>
</label><p>Cardiovascular risk group was calculated from a cardiovascular risk score with points given for history of hypertension, high cholesterol, diabetes, waist to hip ratio, smoking history, and genetic <italic toggle="yes">APOE</italic> genotype.</p></fn></table-wrap-foot></table-wrap><p>At baseline assessment, 3864 participants (0.78%) had a diagnosis of focal epilepsy only, 6397 (1.3%) had a history of stroke only, and 14&#8201;518 (2.93%) had migraine only. There were 134&#8201;249 (27.1%) participants with low cardiovascular risk while 274&#8201;098 (55.4%) and 86&#8201;802 (17.5%) had a moderate and high cardiovascular risk, respectively (eTable 3 in <xref rid="note-NOI230010-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p><sec id="H2-7-NOI230010"><title>Executive Function Between Patient Groups and Controls</title><p>A continuous cognitive function latent variable of executive function was estimated from 5 cognitive tasks of working memory or speed of processing (model and fit indices are shown in eFigure 2 in <xref rid="note-NOI230010-1-s" ref-type="supplementary-material">Supplement 1</xref>). Executive function declined uniformly with age among all groups, consistent with previous findings (<xref rid="noi230010f1" ref-type="fig">Figure 1</xref>).<sup><xref rid="noi230010r22" ref-type="bibr">22</xref>,<xref rid="noi230010r24" ref-type="bibr">24</xref></sup> We controlled for age using a model-free residual method and showed that focal epilepsy was associated with lower executive function than controls and migraine (mean difference, &#8722;0.09; 95% CI, &#8722;0.07 to &#8722;0.10; <italic toggle="yes">t</italic>&#8201;=&#8201;14.70; <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001, and mean difference, &#8722;0.08; 95% CI, &#8722;0.10 to &#8722;0.10; <italic toggle="yes">t</italic>&#8201;=&#8201;&#8722;12.82, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001, respectively, using post hoc Tukey analysis). There was no significant difference between executive function in focal epilepsy or stroke (mean difference, 0.01; 95% CI, &#8722;0.01 to 0.02; <italic toggle="yes">t</italic>&#8201;=&#8201;14.70; post hoc Tukey <italic toggle="yes">P</italic>&#8201;=&#8201;.91) (eTable 4 in <xref rid="note-NOI230010-1-s" ref-type="supplementary-material">Supplement 1</xref>). The associations between executive function and neurological conditions remained consistent with a fully adjusted linear model accounting for other baseline characteristics (eTable 5 in <xref rid="note-NOI230010-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p><fig position="float" id="noi230010f1" fig-type="figure" orientation="portrait"><label>Figure 1. </label><caption><title>Association Between Executive Function and Age in Participants With Epilepsy, Stroke, or Migraine and Control Participants</title><p>Participants with epilepsy and stroke had lower executive function (<italic toggle="yes">z</italic>-scored values) across all ages compared with controls with no history of epilepsy, stroke, or migraine (A). The shaded areas represent standard error. When adjusting for age (B) using an age-residual approach, there was a group difference (<italic toggle="yes">F</italic><sub>3,489&#8201;069</sub>&#8201;=&#8201;201.97, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001). Post hoc pairwise comparison showed that having epilepsy or stroke was associated with significantly lower executive function compared with controls (<italic toggle="yes">t</italic>&#8201;=&#8201;14.70, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001, and <italic toggle="yes">t</italic>&#8201;=&#8201;19.90, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001, respectively, using post hoc Tukey analysis) and participants with migraine (<italic toggle="yes">t</italic>&#8201;=&#8201;&#8722;12.82, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001, and <italic toggle="yes">t</italic>&#8201;=&#8201;&#8722;16.35, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001, respectively). There was no significant difference in executive function between participants with migraine and controls (Tukey analysis <italic toggle="yes">P</italic>&#8201;=&#8201;.91) or between participants with epilepsy or stroke (Tukey analysis <italic toggle="yes">P</italic>&#8201;=&#8201;.91). All groupings shown were mutually exclusive; ie, the epilepsy group had no history of stroke or migraine.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jamaneurol-e230339-g001.jpg"/></fig></sec><sec id="H2-8-NOI230010"><title>Dementia Outcomes</title><p>During the study follow-up, the adjusted HR for incident dementia was 4.02 (95% CI, 3.45-4.68) for participants with focal epilepsy (<xref rid="noi230010f2" ref-type="fig">Figure 2</xref>), which was higher than stroke (HR, 2.56; 95% CI, 2.28-2.87) and migraine (HR, 1.02; 95% CI, 0.85-1.21). Within moderate and high cardiovascular risk groups, having focal epilepsy was associated with a higher risk of developing dementia compared with stroke (<xref rid="noi230010f3" ref-type="fig">Figure 3</xref>). Of participants with high cardiovascular risk and focal epilepsy, 69 of 762 (9.1%) developed dementia compared with 523 of 132&#8201;716 (0.4%) control participants with low cardiovascular risk (HR, 13.66; 95% CI, 10.61-17.60). When considering only individuals with high cardiovascular risk, those with focal epilepsy had an HR of 3.73 (95% CI, 2.94-4.76) for developing dementia compared with controls while participants with stroke had an HR of 1.90 (95% CI, 1.65-2.20) compared with controls. Risks of dementia within moderate and low cardiovascular risk groups are detailed in eTable 6 in <xref rid="note-NOI230010-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p><fig position="float" id="noi230010f2" fig-type="figure" orientation="portrait"><label>Figure 2. </label><caption><title>Risk of Incident Dementia by Neurological Disease Status at Baseline</title><p>The control group had no migraine, stroke, or epilepsy. The model was adjusted for age, sex, education, socioeconomic status, and assessment center.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jamaneurol-e230339-g002.jpg"/></fig><fig position="float" id="noi230010f3" fig-type="figure" orientation="portrait"><label>Figure 3. </label><caption><title>Risk of Incident Dementia Associated With Focal Epilepsy and Stroke According to Cardiovascular (CVS) Risk</title><p>The model was adjusted for age, sex, education, socioeconomic status, and assessment center.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jamaneurol-e230339-g003.jpg"/></fig></sec><sec id="H2-9-NOI230010"><title>Sensitivity Analysis</title><p>Similar patterns of association were observed with epilepsy and stroke when considering risk of incident dementia at 10 years after the baseline assessment and a follow-up period from 5 to 14 years, which was performed to mitigate potential for reverse causation or undetected dementia at baseline (eTable 7 in <xref rid="note-NOI230010-1-s" ref-type="supplementary-material">Supplement 1</xref>). There were 3804 cases of dementia identified for the 10-year follow-up period after baseline assessment and 5110 cases identified for the 5- to 14-year follow-up period. To examine modifiable risk factors more closely, we considered a cardiovascular risk score that did not include genetic <italic toggle="yes">APOE</italic> e4 genotype but instead controlled for the <italic toggle="yes">APOE</italic> e4 genetic risk status in the model. The magnitude of association between each condition and dementia risk was attenuated, but with a similar overall pattern, as participants with high cardiovascular risk and epilepsy had an HR of 7.53 (95% CI, 5.62-10.10) compared with the baseline group of low cardiovascular risk and no epilepsy (eFigure 3 in <xref rid="note-NOI230010-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p></sec><sec id="H2-10-NOI230010"><title>Epilepsy Subanalyses</title><p>Considered an index of epilepsy disease severity, taking more antiseizure medications was associated with lower executive function in those with focal epilepsy (eFigure 4 in <xref rid="note-NOI230010-1-s" ref-type="supplementary-material">Supplement 1</xref>). To control for the possibility that the medications themselves might be affecting cognition, we also examined individuals taking antiseizure medications who did not have a diagnosis of epilepsy. In this group, the association was not present (evidenced by a significant interaction between having a diagnosis of focal epilepsy and number of antiseizure medications, <italic toggle="yes">t</italic>&#8201;=&#8201;2.19, <italic toggle="yes">P</italic>&#8201;=&#8201;.03). The median age at focal epilepsy onset was 25.5 years, which indicated that seizure onset in this epilepsy cohort generally started during adulthood. Despite the use of more antiseizure medications being associated with a lower executive function, using more antiseizure medications was not associated with a higher risk of developing dementia (eTables 8 and 9 in <xref rid="note-NOI230010-1-s" ref-type="supplementary-material">Supplement 1</xref>). The risk of developing dementia associated with late-onset focal epilepsy (age &#8805;50 years) was comparable (HR, 2.82; 95% CI, 1.97-4.04) with the risk associated with early-onset focal epilepsy (age &lt;50 years: HR, 2.46; 95% CI, 1.93-3.13) (eTable 10 in <xref rid="note-NOI230010-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p></sec><sec id="H2-11-NOI230010"><title>Brain Structure Analysis</title><p>Focal epilepsy was associated with lower hippocampal volume (mean difference, &#8722;0.17; 95% CI, &#8722;0.02 to &#8722;0.32; <italic toggle="yes">t</italic>&#8201;=&#8201;&#8722;2.18; <italic toggle="yes">P</italic>&#8201;=&#8201;.03) and lower total gray matter volume (mean difference, &#8722;0.33; 95% CI, &#8722;0.18 to &#8722;0.48; <italic toggle="yes">t</italic>&#8201;=&#8201;&#8722;4.29; <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001) compared with controls (<xref rid="noi230010f4" ref-type="fig">Figure 4</xref>). However, there was no significant difference in white matter hyperintensity volume (mean difference, 0.10; 95% CI, &#8722;0.07 to 0.26; <italic toggle="yes">t</italic>&#8201;=&#8201;1.14; <italic toggle="yes">P</italic>&#8201;=&#8201;.26). Across age, the difference in hippocampal volume was more apparent in older individuals with focal epilepsy. A fully adjusted linear regression model accounting for other baseline characteristics and cardiovascular risk demonstrated the same pattern of associations (eTable 11 in <xref rid="note-NOI230010-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p><fig position="float" id="noi230010f4" fig-type="figure" orientation="portrait"><label>Figure 4. </label><caption><title>Total Hippocampal Volume, Total Gray Matter Volume, and White Matter Hyperintensity Volume in Participants With Focal Epilepsy and Control Participants</title><p>Total hippocampal volume was lower in older individuals with focal epilepsy while total gray matter volume was lower in individuals with focal epilepsy of all ages. When regressing out the effect of age, having epilepsy was significantly associated with lower total hippocampal (mean difference, &#8722;0.17; 95% CI, &#8722;0.02 to &#8722;0.32; <italic toggle="yes">t</italic>&#8201;=&#8201;&#8722;2.18; <italic toggle="yes">P</italic>&#8201;=&#8201;.03) and gray matter volume (mean difference, &#8722;0.33; 95% CI, &#8722;0.18 to &#8722;0.48; <italic toggle="yes">t</italic>&#8201;=&#8201;&#8722;4.29; <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001). No significant difference in white matter hyperintensity was found between individuals with epilepsy and controls (mean difference, 0.10; 95% CI, &#8722;0.07 to 0.26; <italic toggle="yes">t</italic>&#8201;=&#8201;1.14; <italic toggle="yes">P</italic>&#8201;=&#8201;.26).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jamaneurol-e230339-g004.jpg"/></fig></sec></sec><sec id="H1-4-NOI230010"><title>Discussion</title><p>This study showed that having focal epilepsy was associated with worse cognitive function in mid- to late-life individuals compared with controls. Furthermore, by leveraging a large epilepsy cohort with longitudinal data on dementia outcomes, we showed a higher dementia risk in individuals with focal epilepsy compared with those with stroke, which was substantially worse in those with greater cardiovascular risk burden. Focal epilepsy was associated with widespread structural brain change reflected by lower total hippocampal and total gray matter volume.</p><p>Several studies have demonstrated worse cognition in epilepsy as individuals grow older,<sup><xref rid="noi230010r15" ref-type="bibr">15</xref>,<xref rid="noi230010r17" ref-type="bibr">17</xref>,<xref rid="noi230010r35" ref-type="bibr">35</xref>,<xref rid="noi230010r36" ref-type="bibr">36</xref>,<xref rid="noi230010r37" ref-type="bibr">37</xref></sup> although these are mostly cross-sectional and have generally been small in sample size with fewer than a hundred individuals. One study<sup><xref rid="noi230010r38" ref-type="bibr">38</xref></sup> showed objective executive function impairment in a larger epilepsy group (n&#8201;=&#8201;257) prior to starting antiseizure medication. With a sample size an order of magnitude larger than previous studies, our current investigation identified worse cognitive function throughout mid- to late-life individuals with focal epilepsy compared with healthy controls, which was comparable with individuals who had a history of stroke. Taking more antiseizure agents was associated with worse cognition in those with focal epilepsy, which may reflect severity of disease in addition to potential for medication adverse effects. Our findings offer an important contribution to understanding the cognitive impact of epilepsy at a group level.</p><p>Few studies have suggested epilepsy as a risk factor for dementia<sup><xref rid="noi230010r39" ref-type="bibr">39</xref>,<xref rid="noi230010r40" ref-type="bibr">40</xref>,<xref rid="noi230010r41" ref-type="bibr">41</xref>,<xref rid="noi230010r42" ref-type="bibr">42</xref>,<xref rid="noi230010r43" ref-type="bibr">43</xref>,<xref rid="noi230010r44" ref-type="bibr">44</xref></sup> while other investigations did not find an association.<sup><xref rid="noi230010r45" ref-type="bibr">45</xref>,<xref rid="noi230010r46" ref-type="bibr">46</xref>,<xref rid="noi230010r47" ref-type="bibr">47</xref></sup> Stefanidou et al<sup><xref rid="noi230010r48" ref-type="bibr">48</xref></sup> identified an increased dementia risk among 43 people with epilepsy in the Framingham Heart study (HR, 1.9; 95% CI, 1.11-3.57) compared with controls, which was slightly lower than our findings. In such studies, cardiovascular risk factors may be controlled for in analyses models or not considered at all. To investigate the potential effect of cardiovascular burden, we stratified individuals based on a previously published cardiovascular risk score<sup><xref rid="noi230010r22" ref-type="bibr">22</xref></sup> and found more than a 13-fold increased risk of dementia in individuals who have high cardiovascular risk and epilepsy compared with those with no epilepsy and low cardiovascular risk. This increased dementia risk was greater than that of stroke. The lack of association with number of prescribed antiseizure medications excludes an important potential confounder because some older antiseizure medications are also associated with increased vascular risk markers.<sup><xref rid="noi230010r49" ref-type="bibr">49</xref></sup> Dementia risk associated with early-onset and late-onset epilepsy was comparable in our study, which is consistent with other investigations showing that measures of epilepsy disease duration did not correspond with worse cognitive impairment<sup><xref rid="noi230010r50" ref-type="bibr">50</xref></sup> or tau pathology burden.<sup><xref rid="noi230010r6" ref-type="bibr">6</xref></sup> The association between epilepsy and dementia may represent shared risk factors between epilepsy and a vascular dementia-like process<sup><xref rid="noi230010r51" ref-type="bibr">51</xref></sup> or an interplay between mixed underlying pathology, which is increasingly reported in dementia.<sup><xref rid="noi230010r52" ref-type="bibr">52</xref>,<xref rid="noi230010r53" ref-type="bibr">53</xref></sup> In either event, our findings highlight a key clinical message that cardiovascular risk factor modification may be critical for managing cognitive outcomes in focal epilepsy.</p><p>Epilepsy neuroimaging studies have observed widespread structural changes in addition to hippocampal atrophy.<sup><xref rid="noi230010r28" ref-type="bibr">28</xref>,<xref rid="noi230010r29" ref-type="bibr">29</xref>,<xref rid="noi230010r30" ref-type="bibr">30</xref></sup> The present study confirms this finding while incorporating important covariates such as education, socioeconomic status, and cardiovascular risk factors, which are often not considered. Structural changes at the whole brain level may reflect widespread network effects of epilepsy regardless of the focal onset of seizures.<sup><xref rid="noi230010r54" ref-type="bibr">54</xref>,<xref rid="noi230010r55" ref-type="bibr">55</xref></sup> We did not find a statistically significant difference in white matter hyperintensity burden between individuals with epilepsy and controls, although this trend was present. The finding of widespread structural changes in this cohort is important to understand the effects of epilepsy on the brain.</p><sec id="H2-12-NOI230010"><title>Limitations</title><p>Our study has several limitations. Because of the observational nature of this cohort, the association of greater incident dementia in epilepsy cannot be taken as causal. Medical information was based on hospital records, death certificate data, or self-report, which may be incorrect.<sup><xref rid="noi230010r56" ref-type="bibr">56</xref></sup> We identified individuals with nongenetic or focal-onset epilepsy through medical coding; however, this may be inaccurate, and we do not have information on seizure origin, laterality, frequency, or presence of hippocampal sclerosis, which may have an impact on cognitive performance. Such epilepsy characteristics were not captured by the UK Biobank, which was designed to recruit healthy individuals with no single disease in focus. Results of specific clinical investigations, such as electroencephalograms, were not available but would be a beneficial addition to future data releases of the study.</p><p>Data from all participants in the UK Biobank, aged 38 to 72 years, were used to include as many diagnoses of epilepsy, stroke, and migraine as possible. We recognize that the younger participants may have a higher chance of developing dementia in later years past the follow-up period of this study. Despite adjustment for potential confounders, the relatively long follow-up period and additional analysis of dementia incidence from 5 to 14 years, there may be unmeasured confounders and potential for reverse causality. While we considered all-cause dementia risk in our study, examining the relationship with dementia subtypes would be interesting; however, subtypes are currently poorly captured in the UK Biobank, and dementia cases are likely to be Alzheimer disease, vascular, or a mixed picture.<sup><xref rid="noi230010r57" ref-type="bibr">57</xref></sup></p><p>The UK Biobank cohort is generally considered healthy and likely to be from less deprived areas<sup><xref rid="noi230010r58" ref-type="bibr">58</xref></sup>; therefore, the effects of cardiovascular risk may be greater in a more representative cohort. Similarly, individuals with focal epilepsy from this cohort are less likely to have drug-resistant, uncontrolled epilepsy that may result in worse cognitive outcomes.</p></sec></sec><sec id="H1-5-NOI230010"><title>Conclusions</title><p>In this study, focal epilepsy was significantly associated with worse cognitive performance, higher incident dementia risk, and widespread brain differences. Cardiovascular risk was associated with a substantially increased risk of dementia in people with focal epilepsy. Interventions targeting modifiable risk factors may offer an effective management strategy in preventing dementia in individuals with epilepsy.</p></sec></body><back><ref-list id="REF-NOI230010"><title>References</title><ref id="noi230010r1"><label>1</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Hussain</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Haut</surname><given-names>SR</given-names></string-name>, <string-name name-style="western"><surname>Lipton</surname><given-names>RB</given-names></string-name>, <string-name name-style="western"><surname>Derby</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Markowitz</surname><given-names>SY</given-names></string-name>, <string-name name-style="western"><surname>Shinnar</surname><given-names>S</given-names></string-name></person-group>. <article-title>Incidence of epilepsy in a racially diverse, community-dwelling, elderly cohort: results from the Einstein aging study</article-title>. <source>Epilepsy Res</source>. <year>2006</year>;<volume>71</volume>(<issue>2-3</issue>):<fpage>195</fpage>-<lpage>205</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.eplepsyres.2006.06.018</pub-id><pub-id pub-id-type="pmid">16870396</pub-id></mixed-citation></ref><ref id="noi230010r2"><label>2</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Ngugi</surname><given-names>AK</given-names></string-name>, <string-name name-style="western"><surname>Bottomley</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Kleinschmidt</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Sander</surname><given-names>JW</given-names></string-name>, <string-name name-style="western"><surname>Newton</surname><given-names>CR</given-names></string-name></person-group>. <article-title>Estimation of the burden of active and life-time epilepsy: a meta-analytic approach</article-title>. <source>Epilepsia</source>. <year>2010</year>;<volume>51</volume>(<issue>5</issue>):<fpage>883</fpage>-<lpage>890</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1528-1167.2009.02481.x</pub-id><pub-id pub-id-type="pmid">20067507</pub-id><pub-id pub-id-type="pmcid">PMC3410521</pub-id></mixed-citation></ref><ref id="noi230010r3"><label>3</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Subota</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Pham</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Jett&#233;</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Sauro</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Lorenzetti</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Holroyd-Leduc</surname><given-names>J</given-names></string-name></person-group>. <article-title>The association between dementia and epilepsy: a systematic review and meta-analysis</article-title>. <source>Epilepsia</source>. <year>2017</year>;<volume>58</volume>(<issue>6</issue>):<fpage>962</fpage>-<lpage>972</lpage>. doi:<pub-id pub-id-type="doi">10.1111/epi.13744</pub-id><pub-id pub-id-type="pmid">28397967</pub-id></mixed-citation></ref><ref id="noi230010r4"><label>4</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Breteler</surname><given-names>MMB</given-names></string-name>, <string-name name-style="western"><surname>de Groot</surname><given-names>RRM</given-names></string-name>, <string-name name-style="western"><surname>van Romunde</surname><given-names>LKJ</given-names></string-name>, <string-name name-style="western"><surname>Hofman</surname><given-names>A</given-names></string-name></person-group>. <article-title>Risk of dementia in patients with Parkinson&#8217;s disease, epilepsy, and severe head trauma: a register-based follow-up study</article-title>. <source>Am J Epidemiol</source>. <year>1995</year>;<volume>142</volume>(<issue>12</issue>):<fpage>1300</fpage>-<lpage>1305</lpage>. doi:<pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a117597</pub-id><pub-id pub-id-type="pmid">7503050</pub-id></mixed-citation></ref><ref id="noi230010r5"><label>5</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Novak</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Vizjak</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Rakusa</surname><given-names>M</given-names></string-name></person-group>. <article-title>Cognitive impairment in people with epilepsy</article-title>. <source>J Clin Med</source>. <year>2022</year>;<volume>11</volume>(<issue>1</issue>):<fpage>267</fpage>. doi:<pub-id pub-id-type="doi">10.3390/jcm11010267</pub-id><pub-id pub-id-type="pmid">35012007</pub-id><pub-id pub-id-type="pmcid">PMC8746065</pub-id></mixed-citation></ref><ref id="noi230010r6"><label>6</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Tai</surname><given-names>XY</given-names></string-name>, <string-name name-style="western"><surname>Koepp</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Duncan</surname><given-names>JS</given-names></string-name>, <etal/></person-group>. <article-title>Hyperphosphorylated tau in patients with refractory epilepsy correlates with cognitive decline: a study of temporal lobe resections</article-title>. <source>Brain</source>. <year>2016</year>;<volume>139</volume>(<issue>Pt 9</issue>):<fpage>2441</fpage>-<lpage>2455</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/aww187</pub-id><pub-id pub-id-type="pmid">27497924</pub-id><pub-id pub-id-type="pmcid">PMC5926008</pub-id></mixed-citation></ref><ref id="noi230010r7"><label>7</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Thom</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>JY</given-names></string-name>, <string-name name-style="western"><surname>Thompson</surname><given-names>P</given-names></string-name>, <etal/></person-group>. <article-title>Neurofibrillary tangle pathology and Braak staging in chronic epilepsy in relation to traumatic brain injury and hippocampal sclerosis: a post-mortem study</article-title>. <source>Brain</source>. <year>2011</year>;<volume>134</volume>(<issue>Pt 10</issue>):<fpage>2969</fpage>-<lpage>2981</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/awr209</pub-id><pub-id pub-id-type="pmid">21903728</pub-id><pub-id pub-id-type="pmcid">PMC3187539</pub-id></mixed-citation></ref><ref id="noi230010r8"><label>8</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Tai</surname><given-names>XY</given-names></string-name>, <string-name name-style="western"><surname>Bernhardt</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Thom</surname><given-names>M</given-names></string-name>, <etal/></person-group>. <article-title>Review: neurodegenerative processes in temporal lobe epilepsy with hippocampal sclerosis: clinical, pathological and neuroimaging evidence</article-title>. <source>Neuropathol Appl Neurobiol</source>. <year>2018</year>;<volume>44</volume>(<issue>1</issue>):<fpage>70</fpage>-<lpage>90</lpage>. doi:<pub-id pub-id-type="doi">10.1111/nan.12458</pub-id><pub-id pub-id-type="pmid">29288503</pub-id></mixed-citation></ref><ref id="noi230010r9"><label>9</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Livingston</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Huntley</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Sommerlad</surname><given-names>A</given-names></string-name>, <etal/></person-group>. <article-title>Dementia prevention, intervention, and care: 2020 report of the Lancet Commission</article-title>. <source>Lancet</source>. <year>2020</year>;<volume>396</volume>(<issue>10248</issue>):<fpage>413</fpage>-<lpage>446</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(20)30367-6</pub-id><pub-id pub-id-type="pmid">32738937</pub-id><pub-id pub-id-type="pmcid">PMC7392084</pub-id></mixed-citation></ref><ref id="noi230010r10"><label>10</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Tai</surname><given-names>XY</given-names></string-name>, <string-name name-style="western"><surname>Veldsman</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Lyall</surname><given-names>DM</given-names></string-name>, <etal/></person-group>. <article-title>Cardiometabolic multimorbidity, genetic risk, and dementia: a prospective cohort study</article-title>. <source>Lancet Healthy Longev</source>. <year>2022</year>;<volume>3</volume>(<issue>6</issue>):<fpage>e428</fpage>-<lpage>e436</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S2666-7568(22)00117-9</pub-id><pub-id pub-id-type="pmid">35711612</pub-id><pub-id pub-id-type="pmcid">PMC9184258</pub-id></mixed-citation></ref><ref id="noi230010r11"><label>11</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Stefan</surname><given-names>H</given-names></string-name></person-group>. <article-title>Epilepsy in the elderly: facts and challenges</article-title>. <source>Acta Neurol Scand</source>. <year>2011</year>;<volume>124</volume>(<issue>4</issue>):<fpage>223</fpage>-<lpage>237</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1600-0404.2010.01464.x</pub-id><pub-id pub-id-type="pmid">21143593</pub-id></mixed-citation></ref><ref id="noi230010r12"><label>12</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Choi</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Pack</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Elkind</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Longstreth</surname><given-names>WT</given-names><suffix>Jr</suffix></string-name>, <string-name name-style="western"><surname>Ton</surname><given-names>TG</given-names></string-name>, <string-name name-style="western"><surname>Onchiri</surname><given-names>F</given-names></string-name></person-group>. <article-title>Predictors of incident epilepsy in older adults: the Cardiovascular Health Study</article-title>. <source>Neurology</source>. <year>2017</year>;<volume>88</volume>(<issue>9</issue>):<fpage>870</fpage>-<lpage>877</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0000000000003662</pub-id><pub-id pub-id-type="pmid">28130470</pub-id><pub-id pub-id-type="pmcid">PMC5331867</pub-id></mixed-citation></ref><ref id="noi230010r13"><label>13</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Johnson</surname><given-names>EL</given-names></string-name>, <string-name name-style="western"><surname>Krauss</surname><given-names>GL</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>AK</given-names></string-name>, <etal/></person-group>. <article-title>Association between midlife risk factors and late-onset epilepsy: results from the Atherosclerosis Risk in Communities Study</article-title>. <source>JAMA Neurol</source>. <year>2018</year>;<volume>75</volume>(<issue>11</issue>):<fpage>1375</fpage>-<lpage>1382</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamaneurol.2018.1935</pub-id><pub-id pub-id-type="pmid">30039175</pub-id><pub-id pub-id-type="pmcid">PMC6248112</pub-id></mixed-citation></ref><ref id="noi230010r14"><label>14</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>van Tuijl</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>van Raak</surname><given-names>EPM</given-names></string-name>, <string-name name-style="western"><surname>van Oostenbrugge</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Aldenkamp</surname><given-names>AP</given-names></string-name>, <string-name name-style="western"><surname>Rouhl</surname><given-names>RPW</given-names></string-name></person-group>. <article-title>Cognition and quality of life in patients with poststroke epilepsy: a case-control study</article-title>. <source>Epilepsy Behav</source>. <year>2020</year>;<volume>104</volume>(<issue>Pt B</issue>):<elocation-id>106444</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.yebeh.2019.106444</pub-id><pub-id pub-id-type="pmid">31477536</pub-id></mixed-citation></ref><ref id="noi230010r15"><label>15</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Martin</surname><given-names>RC</given-names></string-name>, <string-name name-style="western"><surname>Griffith</surname><given-names>HR</given-names></string-name>, <string-name name-style="western"><surname>Faught</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Gilliam</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Mackey</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Vogtle</surname><given-names>L</given-names></string-name></person-group>. <article-title>Cognitive functioning in community dwelling older adults with chronic partial epilepsy</article-title>. <source>Epilepsia</source>. <year>2005</year>;<volume>46</volume>(<issue>2</issue>):<fpage>298</fpage>-<lpage>303</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.0013-9580.2005.02104.x</pub-id><pub-id pub-id-type="pmid">15679511</pub-id></mixed-citation></ref><ref id="noi230010r16"><label>16</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Griffith</surname><given-names>HR</given-names></string-name>, <string-name name-style="western"><surname>Martin</surname><given-names>RC</given-names></string-name>, <string-name name-style="western"><surname>Bambara</surname><given-names>JK</given-names></string-name>, <string-name name-style="western"><surname>Faught</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Vogtle</surname><given-names>LK</given-names></string-name>, <string-name name-style="western"><surname>Marson</surname><given-names>DC</given-names></string-name></person-group>. <article-title>Cognitive functioning over 3 years in community dwelling older adults with chronic partial epilepsy</article-title>. <source>Epilepsy Res</source>. <year>2007</year>;<volume>74</volume>(<issue>2-3</issue>):<fpage>91</fpage>-<lpage>96</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.eplepsyres.2007.01.002</pub-id><pub-id pub-id-type="pmid">17368001</pub-id></mixed-citation></ref><ref id="noi230010r17"><label>17</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Miller</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Galioto</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Tremont</surname><given-names>G</given-names></string-name>, <etal/></person-group>. <article-title>Cognitive impairment in older adults with epilepsy: characterization and risk factor analysis</article-title>. <source>Epilepsy Behav</source>. <year>2016</year>;<volume>56</volume>:<fpage>113</fpage>-<lpage>117</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.yebeh.2016.01.011</pub-id><pub-id pub-id-type="pmid">26859320</pub-id></mixed-citation></ref><ref id="noi230010r18"><label>18</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Sudlow</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Gallacher</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Allen</surname><given-names>N</given-names></string-name>, <etal/></person-group>. <article-title>UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age</article-title>. <source>PLoS Med</source>. <year>2015</year>;<volume>12</volume>(<issue>3</issue>):<elocation-id>e1001779</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pmed.1001779</pub-id><pub-id pub-id-type="pmid">25826379</pub-id><pub-id pub-id-type="pmcid">PMC4380465</pub-id></mixed-citation></ref><ref id="noi230010r19"><label>19</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Littlejohns</surname><given-names>TJ</given-names></string-name>, <string-name name-style="western"><surname>Holliday</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Gibson</surname><given-names>LM</given-names></string-name>, <etal/></person-group>. <article-title>The UK Biobank imaging enhancement of 100,000 participants: rationale, data collection, management and future directions</article-title>. <source>Nat Commun</source>. <year>2020</year>;<volume>11</volume>(<issue>1</issue>):<fpage>2624</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41467-020-15948-9</pub-id><pub-id pub-id-type="pmid">32457287</pub-id><pub-id pub-id-type="pmcid">PMC7250878</pub-id></mixed-citation></ref><ref id="noi230010r20"><label>20</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Nickels</surname><given-names>KC</given-names></string-name>, <string-name name-style="western"><surname>Wirrell</surname><given-names>EC</given-names></string-name></person-group>. <article-title>Cognitive and social outcomes of epileptic encephalopathies</article-title>. <source>Semin Pediatr Neurol</source>. <year>2017</year>;<volume>24</volume>(<issue>4</issue>):<fpage>264</fpage>-<lpage>275</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.spen.2017.10.001</pub-id><pub-id pub-id-type="pmid">29249506</pub-id></mixed-citation></ref><ref id="noi230010r21"><label>21</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Chowdhury</surname><given-names>FA</given-names></string-name>, <string-name name-style="western"><surname>Silva</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Whatley</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Walker</surname><given-names>MC</given-names></string-name></person-group>. <article-title>Localisation in focal epilepsy: a practical guide</article-title>. <source>Pract Neurol</source>. <year>2021</year>;<volume>21</volume>(<issue>6</issue>):<fpage>481</fpage>-<lpage>491</lpage>. doi:<pub-id pub-id-type="doi">10.1136/practneurol-2019-002341</pub-id><pub-id pub-id-type="pmid">34404748</pub-id></mixed-citation></ref><ref id="noi230010r22"><label>22</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Veldsman</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Tai</surname><given-names>XY</given-names></string-name>, <string-name name-style="western"><surname>Nichols</surname><given-names>T</given-names></string-name>, <etal/></person-group>. <article-title>Cerebrovascular risk factors impact frontoparietal network integrity and executive function in healthy ageing</article-title>. <source>Nat Commun</source>. <year>2020</year>;<volume>11</volume>(<issue>1</issue>):<fpage>4340</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41467-020-18201-5</pub-id><pub-id pub-id-type="pmid">32895386</pub-id><pub-id pub-id-type="pmcid">PMC7477206</pub-id></mixed-citation></ref><ref id="noi230010r23"><label>23</label><mixed-citation publication-type="webpage"><person-group><collab>World Health Organization</collab></person-group>. Waist circumference and waist-hip ratio: report of a WHO expert consultation, Geneva, 8-11 December 2008. Published May 16, <year>2011</year>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/publications/i/item/9789241501491" ext-link-type="uri">https://www.who.int/publications/i/item/9789241501491</ext-link></mixed-citation></ref><ref id="noi230010r24"><label>24</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Tai</surname><given-names>XY</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Manohar</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Husain</surname><given-names>M</given-names></string-name></person-group>. <article-title>Impact of sleep duration on executive function and brain structure</article-title>. <source>Commun Biol</source>. <year>2022</year>;<volume>5</volume>(<issue>1</issue>):<fpage>201</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s42003-022-03123-3</pub-id><pub-id pub-id-type="pmid">35241774</pub-id><pub-id pub-id-type="pmcid">PMC8894343</pub-id></mixed-citation></ref><ref id="noi230010r25"><label>25</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Fawns-Ritchie</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Deary</surname><given-names>IJ</given-names></string-name></person-group>. <article-title>Reliability and validity of the UK Biobank cognitive tests.</article-title><source>PLoS One</source>. <year>2020</year>;<volume>15</volume>(<issue>4</issue>):<elocation-id>e0231627</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0231627</pub-id><pub-id pub-id-type="pmid">32310977</pub-id><pub-id pub-id-type="pmcid">PMC7170235</pub-id></mixed-citation></ref><ref id="noi230010r26"><label>26</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Townsend</surname><given-names>P</given-names></string-name></person-group>. <article-title>Deprivation*</article-title>. <source>J Soc Policy</source>. <year>1987</year>;<volume>16</volume>:<fpage>125</fpage>-<lpage>146</lpage>. doi:<pub-id pub-id-type="doi">10.1017/S0047279400020341</pub-id></mixed-citation></ref><ref id="noi230010r27"><label>27</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Alfaro-Almagro</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Jenkinson</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Bangerter</surname><given-names>NK</given-names></string-name>, <etal/></person-group>. <article-title>Image processing and quality control for the first 10,000 brain imaging datasets from UK Biobank</article-title>. <source>Neuroimage</source>. <year>2018</year>;<volume>166</volume>:<fpage>400</fpage>-<lpage>424</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2017.10.034</pub-id><pub-id pub-id-type="pmid">29079522</pub-id><pub-id pub-id-type="pmcid">PMC5770339</pub-id></mixed-citation></ref><ref id="noi230010r28"><label>28</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Dabbs</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Becker</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Jones</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Rutecki</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Seidenberg</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hermann</surname><given-names>B</given-names></string-name></person-group>. <article-title>Brain structure and aging in chronic temporal lobe epilepsy</article-title>. <source>Epilepsia</source>. <year>2012</year>;<volume>53</volume>(<issue>6</issue>):<fpage>1033</fpage>-<lpage>1043</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1528-1167.2012.03447.x</pub-id><pub-id pub-id-type="pmid">22471353</pub-id><pub-id pub-id-type="pmcid">PMC3710695</pub-id></mixed-citation></ref><ref id="noi230010r29"><label>29</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Caciagli</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Bernasconi</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Wiebe</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Koepp</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Bernasconi</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Bernhardt</surname><given-names>BC</given-names></string-name></person-group>. <article-title>A meta-analysis on progressive atrophy in intractable temporal lobe epilepsy: time is brain?</article-title><source>Neurology</source>. <year>2017</year>;<volume>89</volume>(<issue>5</issue>):<fpage>506</fpage>-<lpage>516</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0000000000004176</pub-id><pub-id pub-id-type="pmid">28687722</pub-id><pub-id pub-id-type="pmcid">PMC5539734</pub-id></mixed-citation></ref><ref id="noi230010r30"><label>30</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Whelan</surname><given-names>CD</given-names></string-name>, <string-name name-style="western"><surname>Altmann</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Bot&#237;a</surname><given-names>JA</given-names></string-name>, <etal/></person-group>. <article-title>Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study</article-title>. <source>Brain</source>. <year>2018</year>;<volume>141</volume>(<issue>2</issue>):<fpage>391</fpage>-<lpage>408</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/awx341</pub-id><pub-id pub-id-type="pmid">29365066</pub-id><pub-id pub-id-type="pmcid">PMC5837616</pub-id></mixed-citation></ref><ref id="noi230010r31"><label>31</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>McDonald</surname><given-names>RP</given-names></string-name>, <string-name name-style="western"><surname>Bollen</surname><given-names>KA</given-names></string-name></person-group>. <article-title>Structural equations with latent variables</article-title>. <source>J Am Stat Assoc</source>. <year>1990</year>;<volume>85</volume>(<issue>412</issue>):<fpage>1175</fpage>-<lpage>1176</lpage>. doi:<pub-id pub-id-type="doi">10.2307/2289630</pub-id></mixed-citation></ref><ref id="noi230010r32"><label>32</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Nobis</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Manohar</surname><given-names>SG</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>SM</given-names></string-name>, <etal/></person-group>. <article-title>Hippocampal volume across age: nomograms derived from over 19,700 people in UK Biobank</article-title>. <source>Neuroimage Clin</source>. <year>2019</year>;<volume>23</volume>:<elocation-id>101904</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.nicl.2019.101904</pub-id><pub-id pub-id-type="pmid">31254939</pub-id><pub-id pub-id-type="pmcid">PMC6603440</pub-id></mixed-citation></ref><ref id="noi230010r33"><label>33</label><mixed-citation publication-type="webpage"><person-group><string-name name-style="western"><surname>Manohar</surname><given-names>SG</given-names></string-name></person-group>. Matlib: MATLAB tools for plotting, data analysis, eye tracking and experiment design (public). Created January 19, <year>2019</year>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://osf.io/VMABG" ext-link-type="uri">https://osf.io/VMABG</ext-link></mixed-citation></ref><ref id="noi230010r34"><label>34</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Rosseel</surname><given-names>Y</given-names></string-name></person-group>. <article-title>Lavaan: an R package for structural equation modeling</article-title>. <source>J Stat Softw</source>. <year>2012</year>;<volume>48</volume>(<issue>2</issue>):<fpage>1</fpage>-<lpage>36</lpage>. doi:<pub-id pub-id-type="doi">10.18637/jss.v048.i02</pub-id></mixed-citation></ref><ref id="noi230010r35"><label>35</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Griffith</surname><given-names>HR</given-names></string-name>, <string-name name-style="western"><surname>Martin</surname><given-names>RC</given-names></string-name>, <string-name name-style="western"><surname>Bambara</surname><given-names>JK</given-names></string-name>, <string-name name-style="western"><surname>Marson</surname><given-names>DC</given-names></string-name>, <string-name name-style="western"><surname>Faught</surname><given-names>E</given-names></string-name></person-group>. <article-title>Older adults with epilepsy demonstrate cognitive impairments compared with patients with amnestic mild cognitive impairment</article-title>. <source>Epilepsy Behav</source>. <year>2006</year>;<volume>8</volume>(<issue>1</issue>):<fpage>161</fpage>-<lpage>168</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.yebeh.2005.09.004</pub-id><pub-id pub-id-type="pmid">16266829</pub-id></mixed-citation></ref><ref id="noi230010r36"><label>36</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Piazzini</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Canevini</surname><given-names>MP</given-names></string-name>, <string-name name-style="western"><surname>Turner</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Chifari</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Canger</surname><given-names>R</given-names></string-name></person-group>. <article-title>Elderly people and epilepsy: cognitive function</article-title>. <source>Epilepsia</source>. <year>2006</year>;<volume>47</volume>(<issue>suppl 5</issue>):<fpage>82</fpage>-<lpage>84</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1528-1167.2006.00884.x</pub-id><pub-id pub-id-type="pmid">17239113</pub-id></mixed-citation></ref><ref id="noi230010r37"><label>37</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Sung</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Jones</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Jackson</surname><given-names>DC</given-names></string-name>, <etal/></person-group>. <article-title>Age-accelerated psychomotor slowing in temporal lobe epilepsy</article-title>. <source>Epilepsy Res</source>. <year>2013</year>;<volume>103</volume>(<issue>2-3</issue>):<fpage>231</fpage>-<lpage>236</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.eplepsyres.2012.08.011</pub-id><pub-id pub-id-type="pmid">22989854</pub-id><pub-id pub-id-type="pmcid">PMC3563928</pub-id></mixed-citation></ref><ref id="noi230010r38"><label>38</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Witt</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Werhahn</surname><given-names>KJ</given-names></string-name>, <string-name name-style="western"><surname>Kr&#228;mer</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Ruckes</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Trinka</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Helmstaedter</surname><given-names>C</given-names></string-name></person-group>. <article-title>Cognitive-behavioral screening in elderly patients with new-onset epilepsy before treatment</article-title>. <source>Acta Neurol Scand</source>. <year>2014</year>;<volume>130</volume>(<issue>3</issue>):<fpage>172</fpage>-<lpage>177</lpage>. doi:<pub-id pub-id-type="doi">10.1111/ane.12260</pub-id><pub-id pub-id-type="pmid">24796793</pub-id></mixed-citation></ref><ref id="noi230010r39"><label>39</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Keret</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Hoang</surname><given-names>TD</given-names></string-name>, <string-name name-style="western"><surname>Xia</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Rosen</surname><given-names>HJ</given-names></string-name>, <string-name name-style="western"><surname>Yaffe</surname><given-names>K</given-names></string-name></person-group>. <article-title>Association of late-onset unprovoked seizures of unknown etiology with the risk of developing dementia in older veterans</article-title>. <source>JAMA Neurol</source>. <year>2020</year>;<volume>77</volume>(<issue>6</issue>):<fpage>710</fpage>-<lpage>715</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamaneurol.2020.0187</pub-id><pub-id pub-id-type="pmid">32150220</pub-id><pub-id pub-id-type="pmcid">PMC7063560</pub-id></mixed-citation></ref><ref id="noi230010r40"><label>40</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Tsai</surname><given-names>ZR</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>HW</given-names></string-name>, <string-name name-style="western"><surname>Tseng</surname><given-names>CH</given-names></string-name>, <etal/></person-group>. <article-title>Late-onset epilepsy and subsequent increased risk of dementia</article-title>. <source>Aging (Albany NY)</source>. <year>2021</year>;<volume>13</volume>(<issue>3</issue>):<fpage>3573</fpage>-<lpage>3587</lpage>. doi:<pub-id pub-id-type="doi">10.18632/aging.202299</pub-id><pub-id pub-id-type="pmid">33429365</pub-id><pub-id pub-id-type="pmcid">PMC7906153</pub-id></mixed-citation></ref><ref id="noi230010r41"><label>41</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Breteler</surname><given-names>MMB</given-names></string-name>, <string-name name-style="western"><surname>van Duijn</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Chandra</surname><given-names>V</given-names></string-name>, <etal/>; <collab>EURODEM Risk Factors Research Group</collab></person-group>. <article-title>Medical history and the risk of Alzheimer&#8217;s disease: a collaborative re-analysis of case-control studies</article-title>. <source>Int J Epidemiol</source>. <year>1991</year>;<volume>20</volume>(<issue>suppl 2</issue>):<fpage>S36</fpage>-<lpage>S42</lpage>. doi:<pub-id pub-id-type="doi">10.1093/ije/20.Supplement_2.S36</pub-id><pub-id pub-id-type="pmid">1833352</pub-id></mixed-citation></ref><ref id="noi230010r42"><label>42</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Johnson</surname><given-names>EL</given-names></string-name>, <string-name name-style="western"><surname>Krauss</surname><given-names>GL</given-names></string-name>, <string-name name-style="western"><surname>Kucharska-Newton</surname><given-names>A</given-names></string-name>, <etal/></person-group>. <article-title>Dementia in late-onset epilepsy: the Atherosclerosis Risk in Communities study</article-title>. <source>Neurology</source>. <year>2020</year>;<volume>95</volume>(<issue>24</issue>):<fpage>e3248</fpage>-<lpage>e3256</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0000000000011080</pub-id><pub-id pub-id-type="pmid">33097597</pub-id><pub-id pub-id-type="pmcid">PMC7836657</pub-id></mixed-citation></ref><ref id="noi230010r43"><label>43</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Ophir</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Ran</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Felix</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Amir</surname><given-names>G</given-names></string-name></person-group>. <article-title>Ten year cumulative incidence of dementia after late onset epilepsy of unknown etiology</article-title>. <source>J Clin Neurosci</source>. <year>2021</year>;<volume>86</volume>:<fpage>247</fpage>-<lpage>251</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jocn.2021.01.030</pub-id><pub-id pub-id-type="pmid">33775336</pub-id></mixed-citation></ref><ref id="noi230010r44"><label>44</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Schnier</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Duncan</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Wilkinson</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Mbizvo</surname><given-names>GK</given-names></string-name>, <string-name name-style="western"><surname>Chin</surname><given-names>RFM</given-names></string-name></person-group>. <article-title>A nationwide, retrospective, data-linkage, cohort study of epilepsy and incident dementia</article-title>. <source>Neurology</source>. <year>2020</year>;<volume>95</volume>(<issue>12</issue>):<fpage>e1686</fpage>-<lpage>e1693</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0000000000010358</pub-id><pub-id pub-id-type="pmid">32680951</pub-id></mixed-citation></ref><ref id="noi230010r45"><label>45</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Carter</surname><given-names>MD</given-names></string-name>, <string-name name-style="western"><surname>Weaver</surname><given-names>DF</given-names></string-name>, <string-name name-style="western"><surname>Joudrey</surname><given-names>HR</given-names></string-name>, <string-name name-style="western"><surname>Carter</surname><given-names>AO</given-names></string-name>, <string-name name-style="western"><surname>Rockwood</surname><given-names>K</given-names></string-name></person-group>. <article-title>Epilepsy and antiepileptic drug use in elderly people as risk factors for dementia</article-title>. <source>J Neurol Sci</source>. <year>2007</year>;<volume>252</volume>(<issue>2</issue>):<fpage>169</fpage>-<lpage>172</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jns.2006.11.004</pub-id><pub-id pub-id-type="pmid">17182059</pub-id></mixed-citation></ref><ref id="noi230010r46"><label>46</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Kokmen</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Beard</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Chandra</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Offord</surname><given-names>KP</given-names></string-name>, <string-name name-style="western"><surname>Schoenberg</surname><given-names>BS</given-names></string-name>, <string-name name-style="western"><surname>Ballard</surname><given-names>DJ</given-names></string-name></person-group>. <article-title>Clinical risk factors for Alzheimer&#8217;s disease: a population-based case-control study</article-title>. <source>Neurology</source>. <year>1991</year>;<volume>41</volume>(<issue>9</issue>):<fpage>1393</fpage>-<lpage>1397</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.41.9.1393</pub-id><pub-id pub-id-type="pmid">1891088</pub-id></mixed-citation></ref><ref id="noi230010r47"><label>47</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Broe</surname><given-names>GA</given-names></string-name>, <string-name name-style="western"><surname>Henderson</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Creasey</surname><given-names>H</given-names></string-name>, <etal/></person-group>. <article-title>A case-control study of Alzheimer&#8217;s disease in Australia</article-title>. <source>Neurology</source>. <year>1990</year>;<volume>40</volume>(<issue>11</issue>):<fpage>1698</fpage>-<lpage>1707</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.40.11.1698</pub-id><pub-id pub-id-type="pmid">2146525</pub-id></mixed-citation></ref><ref id="noi230010r48"><label>48</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Stefanidou</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Beiser</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Himali</surname><given-names>JJ</given-names></string-name>, <etal/></person-group>. <article-title>Bi-directional association between epilepsy and dementia: the Framingham Heart Study</article-title>. <source>Neurology</source>. <year>2020</year>;<volume>95</volume>(<issue>24</issue>):<fpage>e3241</fpage>-<lpage>e3247</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0000000000011077</pub-id><pub-id pub-id-type="pmid">33097599</pub-id><pub-id pub-id-type="pmcid">PMC7836659</pub-id></mixed-citation></ref><ref id="noi230010r49"><label>49</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Lopinto-Khoury</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Mintzer</surname><given-names>S</given-names></string-name></person-group>. <article-title>Antiepileptic drugs and markers of vascular risk</article-title>. <source>Curr Treat Options Neurol</source>. <year>2010</year>;<volume>12</volume>(<issue>4</issue>):<fpage>300</fpage>-<lpage>308</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11940-010-0080-y</pub-id><pub-id pub-id-type="pmid">20842589</pub-id><pub-id pub-id-type="pmcid">PMC2941234</pub-id></mixed-citation></ref><ref id="noi230010r50"><label>50</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Kaestner</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Reyes</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>A</given-names></string-name>, <etal/>; <collab>Alzheimer&#8217;s Disease Neuroimaging Initiative</collab></person-group>. <article-title>Atrophy and cognitive profiles in older adults with temporal lobe epilepsy are similar to mild cognitive impairment</article-title>. <source>Brain</source>. <year>2021</year>;<volume>144</volume>(<issue>1</issue>):<fpage>236</fpage>-<lpage>250</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/awaa397</pub-id><pub-id pub-id-type="pmid">33279986</pub-id><pub-id pub-id-type="pmcid">PMC7880670</pub-id></mixed-citation></ref><ref id="noi230010r51"><label>51</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Sen</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Capelli</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Husain</surname><given-names>M</given-names></string-name></person-group>. <article-title>Cognition and dementia in older patients with epilepsy</article-title>. <source>Brain</source>. <year>2018</year>;<volume>141</volume>(<issue>6</issue>):<fpage>1592</fpage>-<lpage>1608</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/awy022</pub-id><pub-id pub-id-type="pmid">29506031</pub-id><pub-id pub-id-type="pmcid">PMC5972564</pub-id></mixed-citation></ref><ref id="noi230010r52"><label>52</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Arvanitakis</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Capuano</surname><given-names>AW</given-names></string-name>, <string-name name-style="western"><surname>Leurgans</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Bennett</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Schneider</surname><given-names>JA</given-names></string-name></person-group>. <article-title>Relation of cerebral vessel disease to Alzheimer&#8217;s disease dementia and cognitive function in elderly people: a cross-sectional study</article-title>. <source>Lancet Neurol</source>. <year>2016</year>;<volume>15</volume>(<issue>9</issue>):<fpage>934</fpage>-<lpage>943</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1474-4422(16)30029-1</pub-id><pub-id pub-id-type="pmid">27312738</pub-id><pub-id pub-id-type="pmcid">PMC4969105</pub-id></mixed-citation></ref><ref id="noi230010r53"><label>53</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Boyle</surname><given-names>PA</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>L</given-names></string-name>, <etal/></person-group>. <article-title>To what degree is late life cognitive decline driven by age-related neuropathologies?</article-title><source>Brain</source>. <year>2021</year>;<volume>144</volume>(<issue>7</issue>):<fpage>2166</fpage>-<lpage>2175</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/awab092</pub-id><pub-id pub-id-type="pmid">33742668</pub-id><pub-id pub-id-type="pmcid">PMC8370442</pub-id></mixed-citation></ref><ref id="noi230010r54"><label>54</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Englot</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Konrad</surname><given-names>PE</given-names></string-name>, <string-name name-style="western"><surname>Morgan</surname><given-names>VL</given-names></string-name></person-group>. <article-title>Regional and global connectivity disturbances in focal epilepsy, related neurocognitive sequelae, and potential mechanistic underpinnings</article-title>. <source>Epilepsia</source>. <year>2016</year>;<volume>57</volume>(<issue>10</issue>):<fpage>1546</fpage>-<lpage>1557</lpage>. doi:<pub-id pub-id-type="doi">10.1111/epi.13510</pub-id><pub-id pub-id-type="pmid">27554793</pub-id><pub-id pub-id-type="pmcid">PMC5056148</pub-id></mixed-citation></ref><ref id="noi230010r55"><label>55</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Holmes</surname><given-names>GL</given-names></string-name></person-group>. <article-title>Cognitive impairment in epilepsy: the role of network abnormalities</article-title>. <source>Epileptic Disord</source>. <year>2015</year>;<volume>17</volume>(<issue>2</issue>):<fpage>101</fpage>-<lpage>116</lpage>. doi:<pub-id pub-id-type="doi">10.1684/epd.2015.0739</pub-id><pub-id pub-id-type="pmid">25905906</pub-id><pub-id pub-id-type="pmcid">PMC5410366</pub-id></mixed-citation></ref><ref id="noi230010r56"><label>56</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Sibbett</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Russ</surname><given-names>TC</given-names></string-name>, <string-name name-style="western"><surname>Deary</surname><given-names>IJ</given-names></string-name>, <string-name name-style="western"><surname>Starr</surname><given-names>JM</given-names></string-name></person-group>. <article-title>Dementia ascertainment using existing data in UK longitudinal and cohort studies: a systematic review of methodology</article-title>. <source>BMC Psychiatry</source>. <year>2017</year>;<volume>17</volume>(<issue>1</issue>):<fpage>239</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12888-017-1401-4</pub-id><pub-id pub-id-type="pmid">28673273</pub-id><pub-id pub-id-type="pmcid">PMC5496178</pub-id></mixed-citation></ref><ref id="noi230010r57"><label>57</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Wilkinson</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Schnier</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Bush</surname><given-names>K</given-names></string-name>, <etal/>; <collab>Dementias Platform UK and UK Biobank</collab></person-group>. <article-title>Identifying dementia outcomes in UK Biobank: a validation study of primary care, hospital admissions and mortality data</article-title>. <source>Eur J Epidemiol</source>. <year>2019</year>;<volume>34</volume>(<issue>6</issue>):<fpage>557</fpage>-<lpage>565</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10654-019-00499-1</pub-id><pub-id pub-id-type="pmid">30806901</pub-id><pub-id pub-id-type="pmcid">PMC6497624</pub-id></mixed-citation></ref><ref id="noi230010r58"><label>58</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Fry</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Littlejohns</surname><given-names>TJ</given-names></string-name>, <string-name name-style="western"><surname>Sudlow</surname><given-names>C</given-names></string-name>, <etal/></person-group>. <article-title>Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population</article-title>. <source>Am J Epidemiol</source>. <year>2017</year>;<volume>186</volume>(<issue>9</issue>):<fpage>1026</fpage>-<lpage>1034</lpage>. doi:<pub-id pub-id-type="doi">10.1093/aje/kwx246</pub-id><pub-id pub-id-type="pmid">28641372</pub-id><pub-id pub-id-type="pmcid">PMC5860371</pub-id></mixed-citation></ref></ref-list><notes notes-type="supplementary-material" id="note-NOI230010-1"><supplementary-material id="note-NOI230010-1-s" position="float" content-type="local-data" orientation="portrait"><label>Supplement 1.</label><caption><p><bold>eTable 1</bold>. Codes used in the UK Biobank study to identify dementia and cardiometabolic condition cases and exclusion diagnoses</p><p><bold>eTable 2. </bold>Codes for anti-epileptic medication recorded in the UK Biobank and simplified medication name</p><p><bold>eFigure 1.</bold> Study flowchart</p><p><bold>eFigure 2. </bold>Confirmatory factor analysis of computer-based cognitive tasks</p><p><bold>eTable 3. </bold>Cardiovascular risk score breakdown</p><p><bold>eTable 4.</bold> Post-hoc comparisons examining the differences between individual neurological conditions (mutually exclusive groups) and controls</p><p><bold>eTable 5.</bold> Association between Executive Function with neurological conditions using a general linear model controlling for other baseline characteristics</p><p><bold>eTable 6.</bold> Dementia risk for focal epilepsy and stroke within each cardiovascular risk group.</p><p><bold>eTable 7. </bold>Dementia risk for each neurological condition (mutually exclusive groups) with different follow-up periods</p><p><bold>eFigure 3.</bold> Risk of incident dementia associated with focal epilepsy and stroke according to cardiovascular risk groups (calculated without considering APOE e4 status)</p><p><bold>eFigure 4.</bold> Relationship between Executive Function and anti-epileptic medication (number and type)</p><p><bold>eTable 8. </bold>Association between Executive Function and epilepsy-related characteristics within epilepsy sub-group using a general linear model controlling for other baseline characteristics</p><p><bold>eTable 9. </bold>Dementia risk associated with epilepsy-related factors within the sub-group of participants with epilepsy</p><p><bold>eTable 10. </bold>Dementia risk for individuals with early- vs late-onset diagnosis of focal epilepsy</p><p><bold>eTable 11</bold>. Associations between total hippocampal, total grey matter, total white matter hyperintensity volume with neurological conditions of focal epilepsy, stroke and migraine considering other baseline characteristics.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jamaneurol-e230339-s001.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material position="float" content-type="local-data" orientation="portrait"><label>Supplement 2.</label><caption><p>Data sharing statement</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jamaneurol-e230339-s002.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></notes></back></article></pmc-articleset>